Oncology Nursing Society (ONS) member Jane C. Shivnan, MScN, RN, AOCN®, has been named executive director of clinical quality and nursing at Johns Hopkins Medicine International (JHI), the international arm of Johns Hopkins Medicine. Shivnan has more than 20 years of healthcare leadership...

This novel how-to book written quite plainly and matter-of-factly by a family practice physician and a journalist is extremely relevant. Although not all members of the healthcare community are fans of a quick fix of scientific matters, this book serves the reader well in giving practical, ethical...

Crizotinib (Xalkori®), an oral anaplastic lymphoma kinase (ALK) inhibitor, has received U.S. Food and Drug Administration (FDA) approval for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that has tested positive for ALK gene abnormalities.